Much Clinical Trial Information Remains Concealed, Despite Promise To Disclose More Data
Main Category: Pharma Industry / Biotech IndustryArticle Date: 01 Jun 2005 - 9:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The New York Times on Tuesday examined how the pharmaceutical industry remains "sharply divided" on how much information it reveals to the public about new and completed clinical studies. Journal editors and academic scientists in the last year have urged the industry to disclose more data after several drug companies failed to publish studies that showed their antidepressant medications were as effective as placebos (Berenson, ...New York Times, 5/31). Jeffrey Drazen, editor in chief of the New England Journal of Medicine, said last week that GlaxoSmithKline, Merck and Pfizer are not providing useful data on clinical trials they register on the site. In September 2004, the members of the International Committee of Medical Journal Editors announced that they will cease publishing studies that are not registered in an NIH database -- ClinicalTrials.gov -- at the time of their launches. The Pharmaceutical Research and Manufacturers of America and three other major pharmaceutical associations earlier this year recommended to their members that they submit clinical trial information to the public registry beginning in July (Kaiser Daily Health Policy Report, 5/24). According to the Times, "continued gaps in disclosure" have led to support among some members of Congress for new federal laws on the issue. Legislation proposed in February by Sens. Christopher Dodd (D-Conn.) and Chuck Grassley (R-Iowa) would convert ClinicalTrials.gov into a national registry for new studies and results and impose civil penalties of up to $10,000 per day for companies that fail to release trial data. However, Dodd said the bill's chances of passing in this Congress are uncertain (New York Times, 5/31).
The New York Times
"Reprinted with permission from kaisernetwork.org kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/25427.php>
APA
http://www.medicalnewstoday.com/releases/25427.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



